<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
--------------------
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OMEGA PROTEIN CORPORATION
-----------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEVADA 76-0562134
- ----------------------------------------- --------------------------------
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
1717 ST. JAMES PLACE, SUITE 550
HOUSTON, TEXAS 77056
- ----------------------------------------- --------------------------------
(Address of principal executive offices) (Zip Code)
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check the
following box. | |
If this Form relates to the registration of a class of debt securities and is to
become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. | |
Securities to be registered pursuant to Section 12(b) of the Act:
<TABLE>
<CAPTION>
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
<S> <C>
Common Stock, Par Value $.01 New York Stock Exchange
Per Share
</TABLE>
Securities to be registered pursuant to Section 12(g) of the Act:
None
------------------------------------------------------------------------------
(Title of Class)
<PAGE>
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED
The class of capital stock to be registered is designated as Common Stock,
par value $.01 per share. Information regarding such stock is incorporated by
reference from "Description of Capital Stock" on pages 42 through 44 of the
Registrant's preliminary prospectus included in Amendment No. 1 to the
Registrant's registration statement on Form S-1 (File No. 333-44967) filed with
the Securities and Exchange Commission on March 10, 1998 under the Securities
Act of 1933, as amended.
ITEM 2. EXHIBITS
None Applicable
<PAGE>
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized.
OMEGA PROTEIN CORPORATION
By: /S/ Joseph L. von Rosenberg III
-----------------------------------------
Name: Joseph L. von Rosenberg III
Title: Chief Executive Officer and President
Dated: March 26, 1998
<PAGE>
